Formulary Interface Group

The formulary is managed by the North & East Devon Formulary Interface Group (FIG):

  • Dr Tawfique Daneshmend (Chair)
  • Ms Carol Albury
  • Dr Glen Allaway
  • Mrs Beverley Baker
  • Mr Iain Carr
  • Mr Peter Cope
  • Mrs Tracey Foss
  • Mrs Emma Gitsham
  • Dr Susie Harris
  • Dr Andrew Harrison
  • Mrs Alison Hodgetts
  • Mr Matt Howard
  • Dr Simon Kay
  • Mr Matthew Kaye
  • Mrs Carole Knight
  • Dr Stuart Kyle
  • Mrs Denise Lanyon
  • Dr Jess Parker
  • Ms Bethan Rogers
  • Ms Sam Smith
  • Mr Chris Sullivan
  • Mr Darren Wright

See below for the minutes from the North & East Devon Formulary Interface Group (FIG) meetings:

Terms of reference (amended June 2015)

Purpose of the group

To provide a forum for the Northern, Eastern and Western Devon Clinical Commissioning Group (NEW Devon CCG) to work with the provider trusts it commissions to incorporate national and local treatment choices and guidance into a Joint Formulary.

Functions

The Northern & Eastern Devon Formulary Interface Group (FIG) will:

  • Produce, maintain and review a formulary for use across Northern and Eastern Devon. The formulary will comprise the output of processes to support the managed introduction, utilisation and withdrawal of treatments within the local health economy.
  • Ensure treatments approved by local decision making groups are included in the Northern and Eastern Devon Joint Formulary. Local decision making groups include:
    • Devon Clinical Policy Committee
    • North Devon District Hospital Drugs & Therapeutics Committee
    • Royal Devon and Exeter NHS Foundation Trust Drugs & Therapeutics Committee
  • Ensure treatments recommended by a NICE Technology Appraisal are included in the Northern and Eastern Devon Joint Formulary within 90 days of publication
  • Support secondary care use of treatments commissioned by NHS England
  • Adopt treatment focused care pathways and develop formulary guidance to support the safe and appropriate use of treatments included in the formulary
  • Engage with local specialists, generalists, clinical groups and networks to ensure guidance is clinically appropriate and locally relevant
  • Review and update the Joint Formulary according to an agreed work plan, which will be guided by national clinical guidance, new drug technologies and consultation with local clinicians
  • Receive drugs safety update information and consider how this information should be reflected in the formulary
  • Support cost-effective, evidence-based prescribing in line with the stated strategy of the CCG to implement systems that make the best use of valuable health resources.

Membership

The Northern and Eastern Formulary Interface Group is a multi-stakeholder group whose membership is intended to reflect the needs of the localities and organisations involved. A suggested core membership is:

  • Clinical Chair
  • Deputy Clinical Chair
  • GP representation from the Northern and Eastern localities of NEW Devon CCG
  • Consultant, North Devon District Hospital
  • Consultant, Royal Devon and Exeter NHS Foundation Trust
  • Pharmacy Representative, North Devon District Hospital
  • Pharmacy Representative, Royal Devon and Exeter NHS Foundation Trust
  • Medicines Optimisation Pharmacist representation from the Northern and Eastern localities of NEW Devon CCG
  • Nurse / Non-medical prescriber representative, NEW Devon CCG
  • Joint Formularies Pharmacist, NEW Devon CCG
  • Joint Formularies Technician, NEW Devon CCG
  • Clinical Evidence Manager, NEW Devon CCG

Clinical specialists and other stakeholders can be invited to attend relevant meetings.

Meetings and conduct of business

Meetings will be conducted regularly at a frequency agreed by the group, they will be formal and appropriate agenda and minutes produced.

Meetings may be attended in person or via teleconferencing where services exist; administrative support will be provided by the Clinical Effectiveness Team, NEW Devon CCG.

For the group to be quorate there will be at least two medical practitioners, (of whom at least one is a general practitioner) and one pharmacist representative from the CEMO team, NEW Devon CCG.

Governance and reporting arrangements

The Northern and Eastern Devon Formulary Interface Group will provide progress reports to the Clinical Policy Committee. This group reports to the Clinical Commissioning Group Boards.

Minutes of the Northern and Eastern Devon Formulary Interface Group will be made available on the Joint Formulary website.

The terms of reference will be reviewed annually and available on the Joint Formulary website.

Declarations of interests

All members of the committee and attendees will be expected to complete a declaration of interest. The Chair will ask that declarations of interest are made known to the committee members to indicate any issues where there is a personal competing interest whether financial, academic or research. These are then recorded in the minutes of the appropriate meeting.

North and East Devon FIG Minutes 2017

North and East Devon FIG Minutes 2016

North and East Devon FIG Minutes 2015

North and East Devon FIG Minutes 2014

North and East Devon FIG Minutes 2013

 

Home > Formulary > Committee

 

  • First line
  • Second line
  • Specialist
  • Hospital